Chemical Compound
1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-(2,3-dihydro-1-methyl-1H-isoindol-5-yl)-1,4-dihydro-4-oxo-, (+)-; 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Ganefloxacin; Garenfloxacin; Garenoxacin; T 3811
CAS Registry Number
194804-75-6
Primary record
1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-(2,3-dihydro-1-methyl-1H-isoindol-5-yl)-1,4-dihydro-4-oxo-, (+)-; 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Ganefloxacin; Garenfloxacin; Garenoxacin; T 3811
- 库存
- 6,388 克
- 纯度
- 98.7 %
- CAS
- 194804-75-6
化合物标识与属性
- CAS
- 194804-75-6
- PubChem CID
- 124093
- SMILES
- C[C@@H]1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F
- Canonical SMILES
- C[C@H]1NCc2cc(-c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)ccc21
名称与同义词
- Garenoxacin
- Ganefloxacin
- garenoxacine
- garenoxacino
- Garenfloxacin
- 194804-75-6
- garenoxacinum
- Geninax
- garenoxacin hbr
- Ganefl oxacin
- Garenoxacin mesilate
- Garenoxacin mesylate
- Garenoxacin [INN:BAN]
- T-3811
- AC1L3XUP
- GARENOXACIN [MI]
- RefChem:142698
- GARENOXACIN [INN]
- D04OKJ
- Garenoxacin mesilate hydrate
- UNII-V72H9867WB
- Bms 284756
- T-3811MEa
- BMS-284756
- C23H20F2N2O4
- GARENOXACIN [MART.]
- V72H9867WB
- BMS284756
- GARENOXACIN [WHO-DD]
- CHEBI:131716
- DTXSID30173135
- T 3811
- BMS 284756 (*Mesylate salt*)
- CHEMBL215303
- orb1685515
- orb3025507
- SCHEMBL2103727
- DTXCID5095626
- SCHEMBL29364878
- SCHEMBL29870066
- CTK4E1620
- GTPL12402
- AMY8881
- J01MA19
- MSK5768
- BMS-284756 (*Mesylate salt*)
- MFCD08141853
- NJDRXTDGYFKORP-LLVKDONJSA-N
- AIDS080974
- BCPP000224
- AIDS-080974
- BCP01415
- EX-A3040
- T-3811ME
- ZINC3585048
- ANW-53673
- BDBM50481219
- CID124093
- MSK5768-100M
- s5908
- XH1598
- (R)-1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- AKOS015920281
- BCP9000709
- C23-H20-F2-N2-O4
- CID:124093
- CS-4989
- DB06160
- FG23648
- RL02458
- T-3811E
- NCGC00181770-01
- NCGC00181770-05
- AJ-45047
- AN-30214
- AS-86119
- BR-72802
- HY-17460
- S041
- SID:134222367
- ST2402582
- TR-009058
- 223652-82-2 (MESYLATE SALT)
- Garenoxacin Solution in Methanol, 100ug/mL
- NS00069130
- 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid
- J1.099.977D
- A16856
- A25162
- H37162
- 194804-75-6 pound not223652-90-2
- 804G756
- C419689
- Q3758306
- BRD-K77038618-356-01-3
- 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methylisoindolin-5-yl]-4-oxo-quinoline-3-carboxylic acid
- 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
- 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
- (R)-1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carbo
- (R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2, 3-dihydro-1H-5-isoindolyl)-4-oxo-1, 4-dihydro-3-quinolinecarboxylic acid
- (R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinoline-carboxylic acid
- (R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
- 1-cyclopropyl-8-(difluoromethoxy)-7-((1R)-1-methyl-2,3-dihydro-1H-isoindol-2-ium-5-yl)-4-oxoquinoline-3-carboxylate
- 1-cyclopropyl-8-(difluoromethoxy)-7-((1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 1-cyclopropyl-8-(difluoromethoxy)-7-((1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl)-4-oxoquinoline-3-carboxylic acid
- 1-Cyclopropyl-8-(difluoromethoxy)-7-(2,3-dihydro-1beta-methyl-1H-isoindole-5-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
- 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid<br/>BMS 284756<br/>BMS-284756<br/>BMS284756<br/>garenoxacin
- 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methylisoindoline-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-(2,3-dihydro-1-methyl-1H-isoindol-5-yl)-1,4-dihydro-4-oxo-, (+)-; 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Ganefloxacin; Garenfloxacin; Garenoxacin; T 3811
- 1-cyclopropyl-8-[(difluoromethyl)oxy]-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid
- 223652-82-2
- 3-Quinolinecarboxylicacid,1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-
- 7-[(1R)-1beta-Methylisoindoline-5-yl]-1-cyclopropyl-8-(difluoromethoxy)-4(1H)-oxoquinoline-3-carboxylic acid
- 8-(Difluoromethoxy)-1,4-dihydro-7-(2,3-dihydro-1beta-methyl-1H-isoindole-5-yl)-1-cyclopropyl-4-oxoquinoline-3-carboxylic acid
- 91421-42-0